April 22, 2019

Background

swapnil hiremath

The SGLT2i Crescendo with CREDENCE

This week, we will discuss the CREDENCE trial, simply the most important nephrology trial in a generation.

April 8, 2019

Background

swapnil hiremath

How can we ASCEND from the depths of ...

This week we look at the treatment of depression in hemodialysis patients. It is cognitive behavorial therapy versus sertraline.

jama network open

swapnil hiremath

March 19, 2019

Background

Newsflash: Numerous NSAIDs are Nephrotoxic

swapnil hiremath

March 19, 2019

Background

Newsflash: Numerous NSAIDs are Nephrotoxic

Its March. Which means it is NephMadness.

In conjunction with NephMadness - Pain Region discussion, we discuss a recent JAMA Network Open study, reporting higher kidney risk in young men taking NSAIDs.